| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pancreatic Neoplasms | 15 | 2023 | 155 | 3.310 |
Why?
|
| Podocytes | 10 | 2022 | 91 | 2.700 |
Why?
|
| Carcinoma, Pancreatic Ductal | 4 | 2023 | 16 | 1.260 |
Why?
|
| Mice | 21 | 2022 | 1683 | 1.090 |
Why?
|
| MicroRNAs | 2 | 2016 | 47 | 1.010 |
Why?
|
| Neoplastic Stem Cells | 5 | 2020 | 12 | 0.970 |
Why?
|
| Animals | 25 | 2022 | 4722 | 0.900 |
Why?
|
| Proteinuria | 5 | 2017 | 83 | 0.880 |
Why?
|
| CD18 Antigens | 3 | 2008 | 6 | 0.870 |
Why?
|
| Lupus Erythematosus, Systemic | 2 | 2023 | 221 | 0.810 |
Why?
|
| Interferon Type I | 1 | 2022 | 22 | 0.800 |
Why?
|
| Cell Hypoxia | 2 | 2021 | 14 | 0.800 |
Why?
|
| Lupus Nephritis | 1 | 2022 | 30 | 0.790 |
Why?
|
| Immune Evasion | 1 | 2021 | 4 | 0.760 |
Why?
|
| Coloring Agents | 1 | 2021 | 13 | 0.760 |
Why?
|
| AC133 Antigen | 3 | 2020 | 3 | 0.760 |
Why?
|
| Antibodies | 1 | 2021 | 67 | 0.750 |
Why?
|
| High-Throughput Screening Assays | 2 | 2017 | 10 | 0.720 |
Why?
|
| Glomerulosclerosis, Focal Segmental | 3 | 2016 | 47 | 0.720 |
Why?
|
| Renal Agents | 1 | 2017 | 3 | 0.600 |
Why?
|
| Benzazepines | 1 | 2017 | 9 | 0.600 |
Why?
|
| Protective Agents | 1 | 2017 | 11 | 0.600 |
Why?
|
| Drug Discovery | 1 | 2017 | 21 | 0.590 |
Why?
|
| Indoles | 1 | 2017 | 50 | 0.580 |
Why?
|
| Membrane Microdomains | 2 | 2017 | 15 | 0.580 |
Why?
|
| Cell Fractionation | 1 | 2017 | 6 | 0.570 |
Why?
|
| CD11b Antigen | 2 | 2007 | 18 | 0.570 |
Why?
|
| Receptor, ErbB-4 | 1 | 2016 | 3 | 0.560 |
Why?
|
| Receptor, Notch1 | 1 | 2016 | 8 | 0.560 |
Why?
|
| Diabetic Nephropathies | 1 | 2016 | 29 | 0.550 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2016 | 32 | 0.550 |
Why?
|
| Humans | 36 | 2023 | 30959 | 0.550 |
Why?
|
| Up-Regulation | 1 | 2016 | 176 | 0.520 |
Why?
|
| Kidney Glomerulus | 2 | 2016 | 58 | 0.520 |
Why?
|
| Politics | 1 | 2015 | 17 | 0.510 |
Why?
|
| Hydroxyquinolines | 1 | 2015 | 4 | 0.500 |
Why?
|
| Global Health | 1 | 2015 | 58 | 0.500 |
Why?
|
| Integrin beta1 | 1 | 2015 | 9 | 0.500 |
Why?
|
| Sulfonamides | 1 | 2015 | 59 | 0.490 |
Why?
|
| Signal Transduction | 9 | 2020 | 498 | 0.480 |
Why?
|
| Renal Insufficiency, Chronic | 3 | 2022 | 101 | 0.430 |
Why?
|
| Phenanthrenes | 4 | 2022 | 4 | 0.400 |
Why?
|
| Organophosphates | 4 | 2022 | 4 | 0.400 |
Why?
|
| Gene Expression Regulation | 2 | 2009 | 284 | 0.360 |
Why?
|
| Drug Evaluation, Preclinical | 3 | 2019 | 34 | 0.360 |
Why?
|
| Cell Line, Tumor | 9 | 2022 | 272 | 0.350 |
Why?
|
| Interleukin-6 | 2 | 2020 | 112 | 0.340 |
Why?
|
| Integrins | 1 | 2009 | 21 | 0.340 |
Why?
|
| Blood Platelets | 1 | 2009 | 51 | 0.340 |
Why?
|
| Heat-Shock Proteins | 2 | 2019 | 7 | 0.320 |
Why?
|
| Proteomics | 1 | 2009 | 96 | 0.320 |
Why?
|
| Disease Models, Animal | 5 | 2019 | 782 | 0.310 |
Why?
|
| CD11a Antigen | 1 | 2008 | 1 | 0.310 |
Why?
|
| Integrin beta3 | 1 | 2008 | 7 | 0.300 |
Why?
|
| Receptors, Urokinase Plasminogen Activator | 3 | 2017 | 44 | 0.300 |
Why?
|
| Carcinogenesis | 2 | 2017 | 26 | 0.290 |
Why?
|
| Diterpenes | 4 | 2022 | 9 | 0.290 |
Why?
|
| Complement C3b | 1 | 2006 | 2 | 0.280 |
Why?
|
| Intussusception | 2 | 2020 | 7 | 0.270 |
Why?
|
| Models, Molecular | 1 | 2006 | 84 | 0.270 |
Why?
|
| Actins | 2 | 2017 | 46 | 0.270 |
Why?
|
| Epithelial Cells | 2 | 2017 | 91 | 0.260 |
Why?
|
| Focal Adhesions | 2 | 2016 | 9 | 0.260 |
Why?
|
| Bronchiolitis | 1 | 2005 | 1 | 0.250 |
Why?
|
| Croup | 1 | 2005 | 1 | 0.250 |
Why?
|
| Helium | 1 | 2005 | 2 | 0.250 |
Why?
|
| Airway Obstruction | 1 | 2005 | 18 | 0.250 |
Why?
|
| Kidney Diseases | 2 | 2017 | 125 | 0.240 |
Why?
|
| Xenograft Model Antitumor Assays | 3 | 2022 | 25 | 0.240 |
Why?
|
| Apoptosis | 4 | 2019 | 260 | 0.240 |
Why?
|
| Oxygen | 1 | 2005 | 87 | 0.240 |
Why?
|
| Actin Cytoskeleton | 3 | 2022 | 13 | 0.230 |
Why?
|
| Anti-Inflammatory Agents | 2 | 2015 | 103 | 0.230 |
Why?
|
| Transfection | 2 | 2021 | 126 | 0.230 |
Why?
|
| Gene Expression Regulation, Neoplastic | 3 | 2019 | 112 | 0.220 |
Why?
|
| Cell Line | 2 | 2017 | 305 | 0.210 |
Why?
|
| Cell-Free Nucleic Acids | 1 | 2023 | 14 | 0.210 |
Why?
|
| Asthma | 1 | 2005 | 143 | 0.210 |
Why?
|
| Critical Care | 1 | 2005 | 246 | 0.200 |
Why?
|
| Antibodies, Antinuclear | 1 | 2022 | 21 | 0.200 |
Why?
|
| Endoplasmic Reticulum Stress | 2 | 2019 | 7 | 0.200 |
Why?
|
| Toll-Like Receptors | 1 | 2022 | 29 | 0.200 |
Why?
|
| Acute Kidney Injury | 1 | 2022 | 52 | 0.190 |
Why?
|
| Staining and Labeling | 1 | 2021 | 22 | 0.190 |
Why?
|
| Kidney Transplantation | 1 | 2023 | 126 | 0.190 |
Why?
|
| Dynamins | 2 | 2022 | 10 | 0.190 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2021 | 78 | 0.190 |
Why?
|
| Reactive Oxygen Species | 2 | 2019 | 132 | 0.190 |
Why?
|
| Rotavirus Vaccines | 1 | 2020 | 1 | 0.190 |
Why?
|
| Sp1 Transcription Factor | 2 | 2018 | 8 | 0.180 |
Why?
|
| Endoplasmic Reticulum | 2 | 2018 | 27 | 0.180 |
Why?
|
| GTP-Binding Proteins | 1 | 2020 | 11 | 0.180 |
Why?
|
| Cell Differentiation | 1 | 2021 | 151 | 0.180 |
Why?
|
| Stromal Cells | 1 | 2020 | 37 | 0.180 |
Why?
|
| Mice, Inbred C57BL | 5 | 2022 | 466 | 0.180 |
Why?
|
| Homeostasis | 2 | 2018 | 86 | 0.180 |
Why?
|
| Diazooxonorleucine | 1 | 2020 | 1 | 0.170 |
Why?
|
| Hexosamines | 1 | 2020 | 1 | 0.170 |
Why?
|
| Blast Crisis | 1 | 2020 | 2 | 0.170 |
Why?
|
| Receptors, Estrogen | 1 | 2020 | 70 | 0.170 |
Why?
|
| Female | 9 | 2022 | 16965 | 0.170 |
Why?
|
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 2020 | 12 | 0.170 |
Why?
|
| Programmed Cell Death 1 Receptor | 1 | 2020 | 19 | 0.170 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2020 | 15 | 0.170 |
Why?
|
| Mice, Nude | 4 | 2020 | 36 | 0.170 |
Why?
|
| Neoplasm Proteins | 1 | 2020 | 55 | 0.170 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2022 | 337 | 0.170 |
Why?
|
| Epoxy Compounds | 4 | 2022 | 6 | 0.170 |
Why?
|
| SOXB1 Transcription Factors | 1 | 2019 | 4 | 0.170 |
Why?
|
| Adaptation, Psychological | 1 | 2020 | 147 | 0.170 |
Why?
|
| Integrin alphaVbeta3 | 2 | 2017 | 23 | 0.160 |
Why?
|
| Mice, Knockout | 2 | 2016 | 323 | 0.160 |
Why?
|
| Gastrointestinal Microbiome | 1 | 2022 | 211 | 0.160 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 2019 | 54 | 0.160 |
Why?
|
| Plicamycin | 1 | 2018 | 1 | 0.160 |
Why?
|
| ADP Ribose Transferases | 1 | 2018 | 15 | 0.160 |
Why?
|
| Bacterial Toxins | 1 | 2018 | 21 | 0.160 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 2018 | 21 | 0.160 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 2018 | 24 | 0.160 |
Why?
|
| Neoplasms | 1 | 2021 | 261 | 0.150 |
Why?
|
| Mitochondria | 1 | 2018 | 87 | 0.150 |
Why?
|
| Cancer-Associated Fibroblasts | 1 | 2017 | 2 | 0.150 |
Why?
|
| Pseudomonas Infections | 1 | 2018 | 60 | 0.150 |
Why?
|
| Pseudomonas aeruginosa | 1 | 2018 | 79 | 0.150 |
Why?
|
| Glycogen Synthase Kinase 3 beta | 1 | 2017 | 16 | 0.150 |
Why?
|
| Zebrafish | 1 | 2017 | 18 | 0.150 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2017 | 35 | 0.150 |
Why?
|
| Dimerization | 2 | 2008 | 17 | 0.150 |
Why?
|
| Microtubules | 1 | 2017 | 28 | 0.150 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2018 | 79 | 0.150 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2019 | 230 | 0.150 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2017 | 17 | 0.150 |
Why?
|
| Amino Acid Substitution | 2 | 2008 | 26 | 0.150 |
Why?
|
| Apolipoproteins | 1 | 2017 | 9 | 0.150 |
Why?
|
| Interleukin-1 | 1 | 2017 | 79 | 0.150 |
Why?
|
| Lipoproteins, HDL | 1 | 2017 | 30 | 0.140 |
Why?
|
| Phenotype | 2 | 2017 | 377 | 0.140 |
Why?
|
| Doxorubicin | 1 | 2017 | 70 | 0.140 |
Why?
|
| Intracellular Membranes | 1 | 2017 | 32 | 0.140 |
Why?
|
| K562 Cells | 2 | 2007 | 6 | 0.140 |
Why?
|
| Lysosomes | 1 | 2017 | 26 | 0.140 |
Why?
|
| NF-kappa B | 1 | 2017 | 110 | 0.140 |
Why?
|
| Centrifugation, Density Gradient | 1 | 2017 | 12 | 0.140 |
Why?
|
| Immunomagnetic Separation | 1 | 2017 | 4 | 0.140 |
Why?
|
| Ribonucleases | 1 | 2016 | 9 | 0.140 |
Why?
|
| Integrin alpha3beta1 | 1 | 2016 | 1 | 0.140 |
Why?
|
| Extracellular Traps | 1 | 2016 | 4 | 0.140 |
Why?
|
| Myeloid Cells | 1 | 2016 | 16 | 0.140 |
Why?
|
| Erlotinib Hydrochloride | 1 | 2016 | 19 | 0.140 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2016 | 32 | 0.140 |
Why?
|
| Chemokine CCL2 | 1 | 2016 | 24 | 0.140 |
Why?
|
| Lipopolysaccharides | 2 | 2015 | 133 | 0.140 |
Why?
|
| Cell Movement | 2 | 2015 | 105 | 0.140 |
Why?
|
| beta-Glucans | 1 | 2016 | 25 | 0.140 |
Why?
|
| Extracellular Matrix | 1 | 2016 | 75 | 0.140 |
Why?
|
| Cell Proliferation | 4 | 2019 | 204 | 0.130 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2017 | 225 | 0.130 |
Why?
|
| Thiohydantoins | 1 | 2015 | 1 | 0.130 |
Why?
|
| Hyperoxia | 1 | 2015 | 1 | 0.130 |
Why?
|
| Benzoates | 1 | 2015 | 7 | 0.130 |
Why?
|
| Neutrophils | 1 | 2016 | 120 | 0.130 |
Why?
|
| United Nations | 1 | 2015 | 1 | 0.130 |
Why?
|
| Rats | 2 | 2015 | 873 | 0.130 |
Why?
|
| National Health Programs | 1 | 2015 | 5 | 0.130 |
Why?
|
| Economic Development | 1 | 2015 | 4 | 0.130 |
Why?
|
| Bronchopulmonary Dysplasia | 1 | 2015 | 14 | 0.130 |
Why?
|
| Health Care Reform | 1 | 2015 | 20 | 0.130 |
Why?
|
| Puromycin Aminonucleoside | 1 | 2015 | 7 | 0.130 |
Why?
|
| Membrane Proteins | 1 | 2016 | 184 | 0.130 |
Why?
|
| Albuminuria | 1 | 2015 | 22 | 0.120 |
Why?
|
| Disease Progression | 4 | 2020 | 830 | 0.120 |
Why?
|
| Microscopy, Confocal | 1 | 2015 | 118 | 0.120 |
Why?
|
| Male | 8 | 2022 | 16425 | 0.120 |
Why?
|
| Leadership | 1 | 2015 | 103 | 0.120 |
Why?
|
| Xanthones | 1 | 2014 | 2 | 0.120 |
Why?
|
| B7-1 Antigen | 1 | 2013 | 12 | 0.110 |
Why?
|
| Child | 4 | 2020 | 1428 | 0.110 |
Why?
|
| Immunoconjugates | 1 | 2013 | 10 | 0.110 |
Why?
|
| Kidney | 2 | 2022 | 181 | 0.110 |
Why?
|
| Mutagenesis, Site-Directed | 2 | 2019 | 19 | 0.110 |
Why?
|
| Arthritis, Experimental | 1 | 2014 | 132 | 0.100 |
Why?
|
| Mutation | 2 | 2017 | 407 | 0.100 |
Why?
|
| Infant | 3 | 2020 | 578 | 0.100 |
Why?
|
| Ileal Diseases | 1 | 2011 | 1 | 0.090 |
Why?
|
| Choristoma | 1 | 2011 | 9 | 0.090 |
Why?
|
| Pancreas | 1 | 2011 | 37 | 0.090 |
Why?
|
| India | 2 | 2020 | 21 | 0.090 |
Why?
|
| Heterografts | 2 | 2020 | 14 | 0.090 |
Why?
|
| Platelet Aggregation | 1 | 2009 | 7 | 0.090 |
Why?
|
| Risk Factors | 1 | 2016 | 2586 | 0.090 |
Why?
|
| Amino Acid Motifs | 1 | 2009 | 18 | 0.090 |
Why?
|
| Computational Biology | 1 | 2009 | 25 | 0.090 |
Why?
|
| Mass Spectrometry | 1 | 2009 | 43 | 0.090 |
Why?
|
| Phosphorylation | 1 | 2009 | 164 | 0.080 |
Why?
|
| Proteome | 1 | 2009 | 44 | 0.080 |
Why?
|
| Flow Cytometry | 1 | 2009 | 204 | 0.080 |
Why?
|
| Tumor Burden | 2 | 2019 | 33 | 0.080 |
Why?
|
| Unfolded Protein Response | 2 | 2019 | 3 | 0.080 |
Why?
|
| Calcium | 2 | 2017 | 503 | 0.080 |
Why?
|
| Protein Subunits | 1 | 2008 | 21 | 0.080 |
Why?
|
| Lysine | 1 | 2008 | 13 | 0.080 |
Why?
|
| Neoplasm Invasiveness | 2 | 2019 | 87 | 0.080 |
Why?
|
| Arginine | 1 | 2008 | 19 | 0.080 |
Why?
|
| Protein Conformation | 1 | 2008 | 70 | 0.080 |
Why?
|
| Down-Regulation | 2 | 2019 | 112 | 0.070 |
Why?
|
| Cell Death | 2 | 2018 | 61 | 0.070 |
Why?
|
| Cytosol | 2 | 2018 | 63 | 0.070 |
Why?
|
| Receptors, Cell Surface | 1 | 2007 | 48 | 0.070 |
Why?
|
| Amino Acid Sequence | 1 | 2008 | 194 | 0.070 |
Why?
|
| Molecular Sequence Data | 1 | 2008 | 244 | 0.070 |
Why?
|
| Cell Membrane | 1 | 2008 | 106 | 0.070 |
Why?
|
| Antibodies, Blocking | 1 | 2007 | 7 | 0.070 |
Why?
|
| Clone Cells | 1 | 2007 | 22 | 0.070 |
Why?
|
| Molecular Weight | 1 | 2007 | 45 | 0.070 |
Why?
|
| Cell Adhesion | 1 | 2007 | 46 | 0.070 |
Why?
|
| Mice, SCID | 2 | 2017 | 58 | 0.070 |
Why?
|
| Protein Structure, Quaternary | 1 | 2006 | 8 | 0.070 |
Why?
|
| Protein Structure, Secondary | 1 | 2006 | 19 | 0.070 |
Why?
|
| Structure-Activity Relationship | 1 | 2006 | 43 | 0.070 |
Why?
|
| Ligands | 1 | 2006 | 57 | 0.070 |
Why?
|
| Protein Structure, Tertiary | 1 | 2006 | 63 | 0.070 |
Why?
|
| Adolescent | 3 | 2020 | 2399 | 0.070 |
Why?
|
| Magnesium | 1 | 2006 | 49 | 0.070 |
Why?
|
| Young Adult | 3 | 2020 | 2060 | 0.070 |
Why?
|
| Protein Binding | 1 | 2006 | 124 | 0.070 |
Why?
|
| Administration, Inhalation | 1 | 2005 | 27 | 0.060 |
Why?
|
| Respiration, Artificial | 1 | 2005 | 117 | 0.060 |
Why?
|
| Transplant Recipients | 1 | 2023 | 23 | 0.050 |
Why?
|
| Graft Rejection | 1 | 2023 | 74 | 0.050 |
Why?
|
| Epigenesis, Genetic | 1 | 2023 | 78 | 0.050 |
Why?
|
| Tissue Donors | 1 | 2023 | 81 | 0.050 |
Why?
|
| Albumins | 1 | 2022 | 38 | 0.050 |
Why?
|
| Nucleoside Q | 1 | 2022 | 1 | 0.050 |
Why?
|
| Diet, High-Fat | 1 | 2022 | 18 | 0.050 |
Why?
|
| Paclitaxel | 1 | 2022 | 76 | 0.050 |
Why?
|
| DNA Methylation | 1 | 2023 | 133 | 0.050 |
Why?
|
| Oligonucleotides | 1 | 2021 | 2 | 0.050 |
Why?
|
| Models, Biological | 2 | 2017 | 346 | 0.050 |
Why?
|
| Vaccines, Attenuated | 1 | 2020 | 1 | 0.050 |
Why?
|
| Rotavirus Infections | 1 | 2020 | 2 | 0.050 |
Why?
|
| Immunization, Secondary | 1 | 2020 | 7 | 0.050 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2020 | 14 | 0.050 |
Why?
|
| Lactic Acid | 1 | 2020 | 16 | 0.050 |
Why?
|
| Tumor Microenvironment | 1 | 2020 | 18 | 0.050 |
Why?
|
| Product Surveillance, Postmarketing | 1 | 2020 | 17 | 0.050 |
Why?
|
| Vaccination | 1 | 2020 | 48 | 0.050 |
Why?
|
| Administration, Oral | 1 | 2020 | 139 | 0.040 |
Why?
|
| Risk | 1 | 2020 | 220 | 0.040 |
Why?
|
| Adult | 3 | 2020 | 8924 | 0.040 |
Why?
|
| Neoplasm Metastasis | 1 | 2020 | 113 | 0.040 |
Why?
|
| Clustered Regularly Interspaced Short Palindromic Repeats | 1 | 2019 | 2 | 0.040 |
Why?
|
| Octamer Transcription Factor-3 | 1 | 2019 | 2 | 0.040 |
Why?
|
| Tumor Stem Cell Assay | 1 | 2019 | 6 | 0.040 |
Why?
|
| N-Acetylglucosaminyltransferases | 1 | 2019 | 3 | 0.040 |
Why?
|
| Cell Cycle Checkpoints | 1 | 2019 | 6 | 0.040 |
Why?
|
| Glycosylation | 1 | 2019 | 24 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2019 | 18 | 0.040 |
Why?
|
| Cell Self Renewal | 1 | 2019 | 1 | 0.040 |
Why?
|
| DNA Damage | 1 | 2019 | 31 | 0.040 |
Why?
|
| Lipid Metabolism | 1 | 2019 | 33 | 0.040 |
Why?
|
| Gene Knockdown Techniques | 1 | 2019 | 43 | 0.040 |
Why?
|
| Oxidation-Reduction | 1 | 2019 | 72 | 0.040 |
Why?
|
| Chromosomal Proteins, Non-Histone | 1 | 2018 | 3 | 0.040 |
Why?
|
| Bcl-2-Like Protein 11 | 1 | 2018 | 4 | 0.040 |
Why?
|
| Caspase 9 | 1 | 2018 | 12 | 0.040 |
Why?
|
| Obesity | 1 | 2022 | 307 | 0.040 |
Why?
|
| Time-Lapse Imaging | 1 | 2018 | 8 | 0.040 |
Why?
|
| Cytochromes c | 1 | 2018 | 15 | 0.040 |
Why?
|
| Protein Domains | 1 | 2018 | 11 | 0.040 |
Why?
|
| Case-Control Studies | 1 | 2020 | 660 | 0.040 |
Why?
|
| Chondroitin Sulfate Proteoglycans | 1 | 2018 | 29 | 0.040 |
Why?
|
| Caspase 3 | 1 | 2018 | 30 | 0.040 |
Why?
|
| NF-E2-Related Factor 2 | 1 | 2018 | 2 | 0.040 |
Why?
|
| Cell Cycle Proteins | 1 | 2018 | 16 | 0.040 |
Why?
|
| HeLa Cells | 1 | 2018 | 52 | 0.040 |
Why?
|
| Gene Silencing | 1 | 2018 | 24 | 0.040 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2020 | 178 | 0.040 |
Why?
|
| Oxidative Stress | 1 | 2019 | 134 | 0.040 |
Why?
|
| Incidence | 1 | 2020 | 785 | 0.040 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2017 | 19 | 0.040 |
Why?
|
| Receptors, Interleukin-1 | 1 | 2017 | 6 | 0.040 |
Why?
|
| Autocrine Communication | 1 | 2017 | 4 | 0.040 |
Why?
|
| Paracrine Communication | 1 | 2017 | 6 | 0.040 |
Why?
|
| Tumor Cells, Cultured | 1 | 2017 | 149 | 0.040 |
Why?
|
| Cytokines | 1 | 2020 | 351 | 0.040 |
Why?
|
| Child, Preschool | 1 | 2020 | 689 | 0.040 |
Why?
|
| Adenocarcinoma | 1 | 2019 | 206 | 0.040 |
Why?
|
| Apolipoprotein L1 | 1 | 2017 | 8 | 0.040 |
Why?
|
| Surface Plasmon Resonance | 1 | 2017 | 7 | 0.040 |
Why?
|
| Gene Expression | 1 | 2018 | 238 | 0.040 |
Why?
|
| Biomarkers, Tumor | 1 | 2019 | 217 | 0.040 |
Why?
|
| Hypoxia | 1 | 2017 | 63 | 0.040 |
Why?
|
| Cytoskeleton | 1 | 2017 | 52 | 0.040 |
Why?
|
| Microscopy, Fluorescence | 1 | 2017 | 91 | 0.040 |
Why?
|
| Fluorescence Resonance Energy Transfer | 1 | 2016 | 4 | 0.040 |
Why?
|
| Receptor Cross-Talk | 1 | 2016 | 7 | 0.040 |
Why?
|
| Gene Expression Profiling | 1 | 2017 | 164 | 0.040 |
Why?
|
| Fungal Proteins | 1 | 2016 | 7 | 0.040 |
Why?
|
| Macrophage-1 Antigen | 1 | 2016 | 10 | 0.030 |
Why?
|
| Permeability | 1 | 2017 | 139 | 0.030 |
Why?
|
| Transforming Growth Factor beta | 1 | 2017 | 124 | 0.030 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2017 | 91 | 0.030 |
Why?
|
| Prognosis | 1 | 2020 | 919 | 0.030 |
Why?
|
| Alleles | 1 | 2017 | 227 | 0.030 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 2016 | 75 | 0.030 |
Why?
|
| Candida albicans | 1 | 2016 | 22 | 0.030 |
Why?
|
| Cell Separation | 1 | 2016 | 43 | 0.030 |
Why?
|
| Bone Marrow Cells | 1 | 2016 | 59 | 0.030 |
Why?
|
| Adoptive Transfer | 1 | 2016 | 46 | 0.030 |
Why?
|
| rhoA GTP-Binding Protein | 1 | 2016 | 8 | 0.030 |
Why?
|
| Mice, Transgenic | 1 | 2016 | 261 | 0.030 |
Why?
|
| Genotype | 1 | 2017 | 419 | 0.030 |
Why?
|
| Neutrophil Infiltration | 1 | 2015 | 9 | 0.030 |
Why?
|
| Vascular Remodeling | 1 | 2015 | 8 | 0.030 |
Why?
|
| Animals, Newborn | 1 | 2015 | 59 | 0.030 |
Why?
|
| Hypertension, Pulmonary | 1 | 2015 | 17 | 0.030 |
Why?
|
| Cells, Cultured | 1 | 2017 | 686 | 0.030 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2017 | 450 | 0.030 |
Why?
|
| Middle Aged | 2 | 2020 | 10192 | 0.030 |
Why?
|
| Lung | 1 | 2015 | 173 | 0.030 |
Why?
|
| Aged | 2 | 2020 | 10047 | 0.030 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2015 | 468 | 0.030 |
Why?
|
| Antigens | 1 | 2014 | 27 | 0.030 |
Why?
|
| Rats, Wistar | 1 | 2014 | 45 | 0.030 |
Why?
|
| Caspase 1 | 1 | 2014 | 17 | 0.030 |
Why?
|
| Time Factors | 1 | 2018 | 1672 | 0.030 |
Why?
|
| Abatacept | 1 | 2013 | 8 | 0.030 |
Why?
|
| Interleukin-1beta | 1 | 2014 | 61 | 0.030 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2014 | 234 | 0.030 |
Why?
|
| Cohort Studies | 1 | 2017 | 2042 | 0.020 |
Why?
|
| Inflammation | 1 | 2014 | 362 | 0.020 |
Why?
|
| Biomarkers | 1 | 2013 | 733 | 0.020 |
Why?
|
| Gene Transfer Techniques | 1 | 2007 | 36 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2015 | 3806 | 0.020 |
Why?
|